Participant flow15

How many started, completed or left each group, period by period.

1 to 15 of 15

Period	Milestone	Group	Participants
Overall Study	STARTED	LCI699 0.25 mg BID	32
Overall Study	STARTED	LCI699 1 mg QD	26
Overall Study	STARTED	LCI699 0.5 mg Followed by LCI699 1 mg BID	31
Overall Study	STARTED	Eplerenone 50 mg BID	33
Overall Study	STARTED	Placebo	33
Overall Study	COMPLETED	LCI699 0.25 mg BID	23
Overall Study	COMPLETED	LCI699 1 mg QD	22
Overall Study	COMPLETED	LCI699 0.5 mg Followed by LCI699 1 mg BID	28
Overall Study	COMPLETED	Eplerenone 50 mg BID	28
Overall Study	COMPLETED	Placebo	25
Overall Study	NOT COMPLETED	LCI699 0.25 mg BID	9
Overall Study	NOT COMPLETED	LCI699 1 mg QD	4
Overall Study	NOT COMPLETED	LCI699 0.5 mg Followed by LCI699 1 mg BID	3
Overall Study	NOT COMPLETED	Eplerenone 50 mg BID	5
Overall Study	NOT COMPLETED	Placebo	8

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT00817635/flow